{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:54:55Z","timestamp":1740135295939,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["019201","019201","019201","019201"],"award-info":[{"award-number":["019201","019201","019201","019201"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-023-03281-9","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T12:01:42Z","timestamp":1687176102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to: Hypoxia treatment of Parkinson\u2019s disease may disrupt the circadian system"],"prefix":"10.1186","volume":"23","author":[{"given":"Jules M.","family":"Janssen Daalen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjan J.","family":"Meinders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel R.","family":"Straatsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip N.","family":"Ainslie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dick H. J.","family":"Thijssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastiaan R.","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"issue":"6281","key":"3281_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1126\/science.aad9642","volume":"352","author":"IH Jain","year":"2016","unstructured":"Jain IH, Zazzeron L, Goli R, Alexa K, Schatzman-Bone S, Dhillon H, Goldberger O, Peng J, Shalem O, Sanjana NE, et al. Hypoxia as a therapy for mitochondrial disease. Science. 2016;352(6281):54\u201361.","journal-title":"Science"},{"issue":"4","key":"3281_CR2","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cmet.2019.07.006","volume":"30","author":"IH Jain","year":"2019","unstructured":"Jain IH, Zazzeron L, Goldberger O, Marutani E, Wojtkiewicz GR, Ast T, Wang H, Schleifer G, Stepanova A, Brepoels K, et al. Leigh Syndrome Mouse Model Can Be Rescued by Interventions that Normalize Brain Hyperoxia, but Not HIF Activation. Cell Metab. 2019;30(4):824-832 e823.","journal-title":"Cell Metab"},{"issue":"1","key":"3281_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12883-022-02770-7","volume":"22","author":"JM Janssen Daalen","year":"2022","unstructured":"Janssen Daalen JM, Meinders MJ, Giardina F, Roes KCB, Stunnenberg BC, Mathur S, Ainslie PN, Thijssen DHJ, Bloem BR. Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson\u2019s disease: study rationale and protocol. BMC Neurol. 2022;22(1):262.","journal-title":"BMC Neurol"},{"issue":"4","key":"3281_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/mds.28544","volume":"36","author":"J Burtscher","year":"2021","unstructured":"Burtscher J, Syed MMK, Lashuel HA, Millet GP. Hypoxia Conditioning as a Promising Therapeutic Target in Parkinson\u2019s Disease? Mov Disord. 2021;36(4):857\u201361.","journal-title":"Mov Disord"},{"issue":"4","key":"3281_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/01.NPT.0000281255.10174.e2","volume":"30","author":"VE Kelly","year":"2006","unstructured":"Kelly VE, Samii A, Slimp JC, Price R, Goodkin R, Shumway-Cook A. Gait changes in response to subthalamic nucleus stimulation in people with Parkinson disease: a case series report. J Neurol Phys Ther. 2006;30(4):184\u201394.","journal-title":"J Neurol Phys Ther"},{"key":"3281_CR6","doi-asserted-by":"publisher","unstructured":"Coste O, Touitou Y. Hypoxia treatment of Parkinson\u2019s disease may disrupt the circadian system. BMC Neurol. 2023. https:\/\/doi.org\/10.1186\/s12883-023-03270-y.","DOI":"10.1186\/s12883-023-03270-y"},{"issue":"4","key":"3281_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1365-2869.2009.00744.x","volume":"18","author":"O Coste","year":"2009","unstructured":"Coste O, Van Beers P, Touitou Y. Hypoxia-induced changes in recovery sleep, core body temperature, urinary 6-sulphatoxymelatonin and free cortisol after a simulated long-duration flight. J Sleep Res. 2009;18(4):454\u201365.","journal-title":"J Sleep Res"},{"issue":"3","key":"3281_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1081\/CBI-120038611","volume":"21","author":"O Coste","year":"2004","unstructured":"Coste O, Beaumont M, Batejat D, Beers PV, Touitou Y. Prolonged mild hypoxia modifies human circadian core body temperature and may be associated with sleep disturbances. Chronobiol Int. 2004;21(3):419\u201333.","journal-title":"Chronobiol Int"},{"key":"3281_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113709","volume":"341","author":"S Puri","year":"2021","unstructured":"Puri S, Panza G, Mateika JH. A comprehensive review of respiratory, autonomic and cardiovascular responses to intermittent hypoxia in humans. Exp Neurol. 2021;341: 113709.","journal-title":"Exp Neurol"},{"key":"3281_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neulet.2015.11.012","volume":"611","author":"L Shu","year":"2016","unstructured":"Shu L, Wang C, Wang J, Zhang Y, Zhang X, Yang Y, Zhuo J, Liu J. The neuroprotection of hypoxic preconditioning on rat brain against traumatic brain injury by up-regulated transcription factor Nrf2 and HO-1 expression. Neurosci Lett. 2016;611:74\u201380.","journal-title":"Neurosci Lett"},{"issue":"1","key":"3281_CR11","doi-asserted-by":"publisher","first-page":"7899","DOI":"10.1038\/s41598-020-64848-x","volume":"10","author":"A Gangwar","year":"2020","unstructured":"Gangwar A, Paul S, Ahmad Y, Bhargava K. Intermittent hypoxia modulates redox homeostasis, lipid metabolism associated inflammatory processes and redox post-translational modifications: Benefits at high altitude. Sci Rep. 2020;10(1):7899.","journal-title":"Sci Rep"},{"issue":"10","key":"3281_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/01902148.2020.1821263","volume":"46","author":"MA Nimje","year":"2020","unstructured":"Nimje MA, Patir H, Tirpude RK, Reddy PK, Kumar B. Physiological and oxidative stress responses to intermittent hypoxia training in Sprague Dawley rats. Exp Lung Res. 2020;46(10):376\u201392.","journal-title":"Exp Lung Res"},{"key":"3281_CR13","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-Candia A, Candia AA, Paz A, et al. Cardioprotective Antioxidant and Anti-Inflammatory Mechanisms Induced by Intermittent Hypobaric Hypoxia. Antioxidants (Basel). 2022;11(6):1043. Published 2022 May 25. https:\/\/doi.org\/10.3390\/antiox11061043.","DOI":"10.3390\/antiox11061043"},{"issue":"7","key":"3281_CR14","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00424-019-02273-4","volume":"471","author":"A Gangwar","year":"2019","unstructured":"Gangwar A. Pooja, Sharma M, Singh K, Patyal A, Bhaumik G, Bhargava K, Sethy NK: Intermittent normobaric hypoxia facilitates high altitude acclimatization by curtailing hypoxia-induced inflammation and dyslipidemia. Pflugers Arch. 2019;471(7):949\u201359.","journal-title":"Pflugers Arch"},{"issue":"10","key":"3281_CR15","doi-asserted-by":"publisher","first-page":"R1181","DOI":"10.1152\/ajpregu.00208.2014","volume":"307","author":"A Navarrete-Opazo","year":"2014","unstructured":"Navarrete-Opazo A, Mitchell GS. Therapeutic potential of intermittent hypoxia: a matter of dose. Am J Physiol Regul Integr Comp Physiol. 2014;307(10):R1181-1197.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"10","key":"3281_CR16","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.1172\/JCI137560","volume":"130","author":"NR Prabhakar","year":"2020","unstructured":"Prabhakar NR, Peng YJ, Nanduri J. Hypoxia-inducible factors and obstructive sleep apnea. J Clin Invest. 2020;130(10):5042\u201351.","journal-title":"J Clin Invest"},{"key":"3281_CR17","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.2147\/NSS.S388238","volume":"14","author":"L Wang","year":"2022","unstructured":"Wang L, Wei DH, Zhang J, Cao J. Time Under 90% Oxygen Saturation and Systemic Hypertension in Patients with Obstructive Sleep Apnea Syndrome. Nat Sci Sleep. 2022;14:2123\u201332.","journal-title":"Nat Sci Sleep"},{"issue":"4","key":"3281_CR18","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1152\/jappl.2001.91.4.1555","volume":"91","author":"A Xie","year":"2001","unstructured":"Xie A, Skatrud JB, Puleo DS, Morgan BJ. Exposure to hypoxia produces long-lasting sympathetic activation in humans. J Appl Physiol (1985). 2001;91(4):1555\u201362.","journal-title":"J Appl Physiol (1985)"},{"key":"3281_CR19","doi-asserted-by":"publisher","unstructured":"Gabryelska A, Turkiewicz S, Karuga FF, Sochal M, Strzelecki D, Bia\u0142asiewicz P. Disruption of Circadian Rhythm Genes in Obstructive Sleep Apnea Patients-Possible Mechanisms Involved and Clinical Implication. Int J Mol Sci. 2022;23(2):709. Published 2022 Jan 10. https:\/\/doi.org\/10.3390\/ijms23020709.","DOI":"10.3390\/ijms23020709"},{"issue":"5","key":"3281_CR20","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s10072-019-04211-9","volume":"41","author":"AP Sun","year":"2020","unstructured":"Sun AP, Liu N, Zhang YS, Zhao HY, Liu XL. The relationship between obstructive sleep apnea and Parkinson\u2019s disease: a systematic review and meta-analysis. Neurol Sci. 2020;41(5):1153\u201362.","journal-title":"Neurol Sci"},{"issue":"10","key":"3281_CR21","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.5665\/sleep.5042","volume":"38","author":"E Sapin","year":"2015","unstructured":"Sapin E, Peyron C, Roche F, Gay N, Carcenac C, Savasta M, Levy P, Dematteis M. Chronic Intermittent Hypoxia Induces Chronic Low-Grade Neuroinflammation in the Dorsal Hippocampus of Mice. Sleep. 2015;38(10):1537\u201346.","journal-title":"Sleep"},{"key":"3281_CR22","doi-asserted-by":"publisher","unstructured":"Snyder B, Shell B, Cunningham JT, Cunningham RL. Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early-stage neurodegeneration. Physiol Rep. 2017;5(9):e13258. https:\/\/doi.org\/10.14814\/phy2.13258.","DOI":"10.14814\/phy2.13258"},{"issue":"1","key":"3281_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1183\/09031936.00027406","volume":"29","author":"WT McNicholas","year":"2007","unstructured":"McNicholas WT, Bonsigore MR. Management Committee of ECAB: Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J. 2007;29(1):156\u201378.","journal-title":"Eur Respir J"},{"key":"3281_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.628168","volume":"12","author":"X Wu","year":"2021","unstructured":"Wu X, Gong L, Xie L, Gu W, Wang X, Liu Z, Li S. NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea. Front Immunol. 2021;12: 628168.","journal-title":"Front Immunol"},{"issue":"28","key":"3281_CR25","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.2174\/092986711797200426","volume":"18","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Yan J, Chang Y, ShiDu Yan S, Shi H. Hypoxia inducible factor-1 as a target for neurodegenerative diseases. Curr Med Chem. 2011;18(28):4335\u201343.","journal-title":"Curr Med Chem"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03281-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03281-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03281-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T12:01:47Z","timestamp":1687176107000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03281-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3281"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03281-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"8 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is performed according to the 2013 \u2018Declaration of Helsinki\u2019 and \u2018<i>the Medical Research Involving Human Subjects Act<\/i> (WMO)\u2019 of the Civil Code of the Netherlands. This study has been approved by the Medical Research Ethics Committee East Netherlands, The Netherlands, (reference number NL.77891.091.22) and has been registered at clinicaltrials.gov (ClinicalTrials.gov Identifier: NCT05214287). Participants are covered by trial insurance issued specifically for this study by Radboud University Medical Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Bastiaan R. Bloem has received honoraria from serving on the scientific advisory board for Abbvie, Biogen, UCB, and Walk with Path; has received fees for speaking at conferences from AbbVie, Zambon, Roche, GE Healthcare, and Bial; and has received research support from The Netherlands Organisation for Scientific Research, the Michael J. Fox Foundation, UCB, Abbvie, the Stichting Parkinson Fonds, the Hersenstichting Nederland, the Parkinson Foundation, Verily Life Sciences, Horizon 2020, the Topsector Life Sciences and Health, and the Parkinson Vereniging. The other authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}